PhaseRx - LaidLaw Capital Markets

Skip to content

Capital Markets
- Transactions
Capital Markets Team
Equity Research
- Research Coverage List
Case Studies
Contact Us
Back to Laidlaw & Company

Previous Next

PhaseRx
admin2018-05-04T15:46:19-04:00

Project Description

Initial Public Offering
Common Stock

$18,500,000

Book Runner
May 2016

Site Info

Home
Contact Us

Legal

Terms & Conditions
Legal Information
Privacy Policy
Glossary Record of Processing Activities
GDPR Rights Exercise Form

Disclosures

FINRA
SIPC
FCA
Business Continuity Plan Disclosure
SEC Order Routing Disclosure
Brokercheck

Copyright 2020 Laidlaw & Company (UK) Ltd. - All Rights Reserved. Laidlaw & Company (UK) Ltd., a FINRA broker-dealer registered in the United States, clears on a fully-disclosed basis through INTL FCStone Financial Inc., a member of the Securities Investor Protection Corporation (SIPC). Laidlaw & Company International Limited is authorized and regulated by the Financial Conduct Authority (FCA) in the UK (Firm Reference No: 537165).

Toggle Sliding Bar Area

Research Coverage List
Research Overview